Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial

The Original Article was published on 17 December 2020

Correction to: Nature Medicine https://doi.org/10.1038/s41591-020-01194-5, published online 17 December 2020.

In the version of this article initially published, the following names were missing from the author list for the Oxford COVID Vaccine Trial Group: Francesca R. Donnellan, Giacomo Gorini, Gaurav Gupta, Nathifa Moya, Ekta Mukhopadhyay, Fay L. Nugent, Stephannie Salvador, Iman Satti and Iona Jennifer Taylor (all at affiliation 1); Carla Ferreira Da Silva, Natalie G. Marchevsky, Daniel Phillips, Christine S. Rollier, Lisa Stockdale, Adriana Tomic and Marije K. Verheul (all at affiliation 2); Miles W. Carroll (at affiliation 7); and Annina Schmid (at affiliation 9). Also, two author names (Rachel Varughes and Gary Mallett) were incorrect; the correct names are ‘Rachel Varughese’ and ‘Garry Mallett’ (respectively). The errors have been corrected in the HTML and PDF versions of the article.

Author information

Affiliations

Authors

Consortia

Corresponding authors

Correspondence to Katie J. Ewer or Teresa Lambe.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ewer, K.J., Barrett, J.R., Belij-Rammerstorfer, S. et al. Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial. Nat Med 27, 1116 (2021). https://doi.org/10.1038/s41591-021-01363-0

Download citation

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing